Nadia Urosevic

Nadia Urosevic is an Adjunct Senior Research Fellow at the School of Biomedical Sciences, The University of Western Australia, with additional appointments in the UWA Medical School and Pathology & Laboratory Medicine department. Her research focuses on microbiology, immunology, and virology with particular expertise in flavivirus research, blood culture diagnostics, and sepsis management.

Dr. Urosevic holds a PhD in Molecular Biology, an MSc in Biochemistry, and a BSc in Physiology and Molecular Biology all from the University of Belgrade. Her educational background has provided a strong foundation for her interdisciplinary research spanning microbiology, immunology, and medical diagnostics.

Her research interests encompass a wide range of topics including Flavivirus (100% of her research fingerprint), Virus (67%), Murray Valley Encephalitis Virus (48%), Chromosome 5 (38%), Lipid Metabolism (32%), Mouse Strain (27%), Congenic (24%), and Infectious Agent (21%). Her work significantly contributes to UN Sustainable Development Goals related to health and wellbeing.

Dr. Urosevic's recent publications demonstrate a strong focus on improving diagnostic techniques for blood cultures and sepsis management. Her work bridges laboratory research with clinical applications, particularly in developing faster and more accurate methods for identifying pathogens in blood cultures. Her research on flaviviruses and antimicrobial resistance has important implications for public health policy and clinical practice.

• 40 research outputs
• 1935 citations
• h-index of 15

She has secured significant research funding through multiple grants including the RTP - Round 12 - Sepsis FASTtrack project (2018-2021), Synthesis and Purification of Flavivirus - Specific Antiviral Factor Mrasal (2003-2004), and the WA Program on Neurobiology & Genetics of Schizophrenia (2002-2004).

Dr. Urosevic collaborates extensively with researchers including T.J.J. Inglis, N.M. Bzdyl, and M.J. Leung, demonstrating her integration into multidisciplinary research teams focused on improving clinical microbiology diagnostics and patient outcomes.